nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0827	0.0834	CcSEcCtD
Perhexiline—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.074	0.0746	CcSEcCtD
Perhexiline—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0638	0.0644	CcSEcCtD
Perhexiline—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0622	0.0628	CcSEcCtD
Perhexiline—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0452	0.0456	CcSEcCtD
Perhexiline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0425	0.0429	CcSEcCtD
Perhexiline—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0399	0.0402	CcSEcCtD
Perhexiline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0353	0.0357	CcSEcCtD
Perhexiline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0341	0.0344	CcSEcCtD
Perhexiline—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0334	0.0337	CcSEcCtD
Perhexiline—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0313	0.0315	CcSEcCtD
Perhexiline—Tension—Riluzole—amyotrophic lateral sclerosis	0.0267	0.0269	CcSEcCtD
Perhexiline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0264	0.0267	CcSEcCtD
Perhexiline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0255	0.0257	CcSEcCtD
Perhexiline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0244	0.0246	CcSEcCtD
Perhexiline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0239	0.0241	CcSEcCtD
Perhexiline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0236	0.0238	CcSEcCtD
Perhexiline—Shock—Riluzole—amyotrophic lateral sclerosis	0.0218	0.022	CcSEcCtD
Perhexiline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0215	0.0217	CcSEcCtD
Perhexiline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0214	CcSEcCtD
Perhexiline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0201	0.0203	CcSEcCtD
Perhexiline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0201	CcSEcCtD
Perhexiline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0195	CcSEcCtD
Perhexiline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0193	CcSEcCtD
Perhexiline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0183	CcSEcCtD
Perhexiline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0178	CcSEcCtD
Perhexiline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0177	CcSEcCtD
Perhexiline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0161	CcSEcCtD
Perhexiline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0148	CcSEcCtD
Perhexiline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0142	CcSEcCtD
Perhexiline—Rash—Riluzole—amyotrophic lateral sclerosis	0.014	0.0141	CcSEcCtD
Perhexiline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.014	0.0141	CcSEcCtD
Perhexiline—Headache—Riluzole—amyotrophic lateral sclerosis	0.0139	0.014	CcSEcCtD
Perhexiline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0133	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0007	0.0812	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000419	0.0486	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000333	0.0386	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000304	0.0353	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000283	0.0329	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000273	0.0317	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00027	0.0313	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00027	0.0313	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00027	0.0313	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000266	0.0309	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000265	0.0307	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000231	0.0268	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000211	0.0245	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000196	0.0228	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000186	0.0216	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000184	0.0214	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000182	0.0212	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000148	0.0172	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000148	0.0172	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00014	0.0162	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000138	0.016	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000136	0.0157	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000126	0.0147	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000126	0.0146	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000124	0.0144	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000118	0.0138	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000107	0.0124	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000103	0.0119	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000103	0.0119	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.58e-05	0.0111	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—VAPA—amyotrophic lateral sclerosis	9.4e-05	0.0109	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.74e-05	0.0101	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	8.59e-05	0.00997	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—FIG4—amyotrophic lateral sclerosis	8.21e-05	0.00954	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.12e-05	0.00943	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSR—amyotrophic lateral sclerosis	7.5e-05	0.0087	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—DAO—amyotrophic lateral sclerosis	7.43e-05	0.00862	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.09e-05	0.00823	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	6.97e-05	0.00809	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	6.93e-05	0.00804	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.83e-05	0.00792	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.16e-05	0.00715	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.92e-05	0.00687	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PLB1—amyotrophic lateral sclerosis	5.63e-05	0.00654	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.62e-05	0.00652	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSR—amyotrophic lateral sclerosis	5.2e-05	0.00603	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.93e-05	0.00572	CbGpPWpGaD
Perhexiline—CPT2—medulla oblongata—amyotrophic lateral sclerosis	4.74e-05	0.123	CbGeAlD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.73e-05	0.00549	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CHAT—amyotrophic lateral sclerosis	4.27e-05	0.00495	CbGpPWpGaD
Perhexiline—CPT2—spinal cord—amyotrophic lateral sclerosis	4.22e-05	0.11	CbGeAlD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.89e-05	0.00452	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.85e-05	0.00447	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	3.65e-05	0.00424	CbGpPWpGaD
Perhexiline—CPT2—nervous system—amyotrophic lateral sclerosis	3.56e-05	0.0926	CbGeAlD
Perhexiline—CPT1A—cerebellum—amyotrophic lateral sclerosis	3.53e-05	0.0918	CbGeAlD
Perhexiline—CPT2—central nervous system—amyotrophic lateral sclerosis	3.43e-05	0.0891	CbGeAlD
Perhexiline—CPT2—cerebellum—amyotrophic lateral sclerosis	3.35e-05	0.0871	CbGeAlD
Perhexiline—CPT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.31e-05	0.00384	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.22e-05	0.00374	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.17e-05	0.00368	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.13e-05	0.00363	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.04e-05	0.00353	CbGpPWpGaD
Perhexiline—CPT1A—brain—amyotrophic lateral sclerosis	2.87e-05	0.0746	CbGeAlD
Perhexiline—CPT2—brain—amyotrophic lateral sclerosis	2.72e-05	0.0708	CbGeAlD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.67e-05	0.0031	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—APOE—amyotrophic lateral sclerosis	2.5e-05	0.0029	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.43e-05	0.00282	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.43e-05	0.00282	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.29e-05	0.00266	CbGpPWpGaD
Perhexiline—CYP2D6—hindbrain—amyotrophic lateral sclerosis	2.29e-05	0.0596	CbGeAlD
Perhexiline—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.22e-05	0.00258	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.21e-05	0.00256	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.00252	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.11e-05	0.00245	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.07e-05	0.0024	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.94e-05	0.00226	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.76e-05	0.00204	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—APOE—amyotrophic lateral sclerosis	1.73e-05	0.00201	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.71e-05	0.00199	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.69e-05	0.00196	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.69e-05	0.00196	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.55e-05	0.00179	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.44e-05	0.00167	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.44e-05	0.00167	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.42e-05	0.00165	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.35e-05	0.00157	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.33e-05	0.00155	CbGpPWpGaD
Perhexiline—CYP2D6—brainstem—amyotrophic lateral sclerosis	1.31e-05	0.0342	CbGeAlD
Perhexiline—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.00143	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.22e-05	0.00142	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.19e-05	0.00138	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.1e-05	0.00128	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.1e-05	0.00128	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.01e-05	0.00117	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.00117	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.39e-06	0.00109	CbGpPWpGaD
Perhexiline—CYP2B6—nervous system—amyotrophic lateral sclerosis	9.26e-06	0.0241	CbGeAlD
Perhexiline—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	9.26e-06	0.00107	CbGpPWpGaD
Perhexiline—CYP2B6—central nervous system—amyotrophic lateral sclerosis	8.92e-06	0.0232	CbGeAlD
Perhexiline—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.83e-06	0.00103	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	8.54e-06	0.000992	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.99e-06	0.000927	CbGpPWpGaD
Perhexiline—CYP2B6—brain—amyotrophic lateral sclerosis	7.08e-06	0.0184	CbGeAlD
Perhexiline—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.02e-06	0.000815	CbGpPWpGaD
Perhexiline—CYP3A4—nervous system—amyotrophic lateral sclerosis	6.99e-06	0.0182	CbGeAlD
Perhexiline—CYP2D6—nervous system—amyotrophic lateral sclerosis	6.88e-06	0.0179	CbGeAlD
Perhexiline—CYP3A4—central nervous system—amyotrophic lateral sclerosis	6.73e-06	0.0175	CbGeAlD
Perhexiline—CYP2D6—central nervous system—amyotrophic lateral sclerosis	6.63e-06	0.0172	CbGeAlD
Perhexiline—CYP2D6—cerebellum—amyotrophic lateral sclerosis	6.48e-06	0.0169	CbGeAlD
Perhexiline—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.05e-06	0.000703	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.59e-06	0.000649	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.43e-06	0.00063	CbGpPWpGaD
Perhexiline—CYP2D6—brain—amyotrophic lateral sclerosis	5.26e-06	0.0137	CbGeAlD
Perhexiline—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.99e-06	0.000579	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.59e-06	0.000533	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	4.1e-06	0.000476	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.77e-06	0.000438	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.47e-06	0.000402	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.85e-06	0.000331	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.81e-06	0.000326	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.47e-06	0.000286	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.27e-06	0.000263	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.95e-06	0.000227	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.86e-06	0.000216	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.28e-06	0.000148	CbGpPWpGaD
